The feasibility study of CE nucleus cochlear implants
This study is to evaluate new approaches to device fitting and diagnostics for cochlear implant users. The evaluation can be performed in the laboratory in an acute session or in real world environments with take-home device use to further validate their benefits. Each feature will be tested in a sub-study specific to that hearing care model. On average, each sub-study is expected to include approximately 20 subjects.
The clinical trial started in October 19, 2020 and will continue throughout January 2025.
Mean difference between standard and novel fitting method for monosyllabic word scores in quiet will be primary outcome measure. Percent correct word scores.
For more details:
